Emerging data have shown that these factors also contribute to the pathological process of MG [24–29]; for example, in a study of AChR-immunized IL-6−/− mice, decreases in the anti-AChR antibody titer and C3 levels, and a relatively low proportion of the mice developed experimental autoimmune MG [29]. This evidence concerns the gene IL6 and myasthenia gravis.